SCHEMBL17035007

SCHEMBL17035007

c1ccc(-c2cc(-c3nc(-c4ccc5ccccc5c4)nc(-c4ccc5ccccc5c4)n3)cc(-c3cc4c(-c5ccccc5)nc5ccccc5c4c4ccccc34)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ATM Q13315 1/20 0.42
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
ADORA2A P29274 5/20 0.37
ADORA1 P30542 4/20 0.37
DHODH Q02127 2/20 0.35
NUDT1 P36639 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ACACA Q13085 2/20 0.34
WHR1 P49842 1/20 0.34
ADORA2B P29275 1/20 0.34
PDE10A Q9Y233 1/20 0.34
CCR4 P51679 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035010 0.95 MEN1 (0.45) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035005 0.93 MEN1 (0.44) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035013 0.92 MEN1 (0.40) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035001 0.91 MEN1 (0.48) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035016 0.91 MEN1 (0.50) MEN1KMT2AATMADORA2ADHODH
SCHEMBL17035183 0.91 MEN1 (0.40) MEN1KMT2AATMAURKAAURKB
SCHEMBL18200352 0.91 MEN1 (0.39) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035009 0.90 CYP11B1 (0.48) MEN1KMT2ADHODHALDH1A1CYP1A2
SCHEMBL18200541 0.90 MEN1 (0.41) MEN1KMT2AATMAURKAAURKB
SCHEMBL17034957 0.90 MEN1 (0.46) MEN1KMT2AATMAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MEN1 476/4885KMT2A 2092/4885ATM 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.